Japan Surgical Sutures Market

Japan Surgical Sutures Market Size and Share:

The Japan surgical sutures market size was valued at USD 319 Million in 2024. Looking forward, IMARC Group estimates the market to reach USD 553 Million by 2033, exhibiting a CAGR of 6.30% from 2025-2033.  The market is driven by an aging population, increasing surgical procedures, and rising cases of chronic diseases. Additionally, the growing preference for absorbable sutures and precision surgical techniques is enhancing market growth. Government support, healthcare infrastructure expansion, and rising healthcare expenditures further contribute to the Japan surgical sutures market share.

The Japan surgical sutures market is primarily driven by the rising prevalence of surgical procedures due to an aging population and increasing incidences of chronic diseases. Japan's senior demographic has attained an unprecedented figure of 36.25 Million, constituting 29.3% of the overall population, which is the highest percentage in the world. Of this group, 20.53 Million are women and 15.72 Million are men. Additionally, last year saw 9.14 Million seniors engaged in the workforce. Following a trend of population decline for 13 consecutive years, forecasts suggest that by 2040, the elderly will represent 34.8% of Japan's total population. Japan has one of the world's highest life expectancies, leading to a growing elderly demographic that requires surgical interventions for conditions such as cardiovascular diseases, orthopedic disorders, and cancer. According to the Japan surgical sutures market research report, advancements in minimally invasive surgical techniques are fueling demand for high-quality sutures that enhance wound healing and reduce recovery time. Moreover, government initiatives supporting healthcare infrastructure development and technological innovation further contribute to the market’s expansion by ensuring access to advanced medical products.

In addition, the growing adoption of absorbable sutures is driven by the preference for improved patient outcomes and reduced post-operative complications. The increasing focus on precision surgery and robotic-assisted procedures is increasing the need for sutures with superior tensile strength and biocompatibility. According to the Japan surgical sutures market analysis, rising healthcare expenditures and reimbursement policies that support advanced surgical procedures encourage hospitals and clinics to invest in high-performance sutures. Japan's medical and welfare sector, currently the third largest industry, is anticipated to become the largest by the years 2035 to 2040. Projections indicate that healthcare expenditures will increase to ¥89 Trillion (approximately USD 600 Billion) by 2040, representing a 1.6-fold increase from the levels observed in 2023. Should tax rates remain stable, this situation may result in a funding deficit of ¥27 Trillion (around USD 180 Billion). Furthermore, the presence of key market players and continuous research and development efforts aimed at enhancing suture materials and coating further bolster Japan surgical sutures market growth.

Japan Surgical Sutures Market Trends:

Increasing Adoption of Biodegradable and Antimicrobial Sutures

A significant trend in the Japan surgical sutures market is the growing preference for biodegradable and antimicrobial sutures. Biodegradable sutures, particularly those made from polyglycolic acid and polylactic acid, are gaining attention due to their ability to dissolve naturally, avoiding the need for suture removal, and decreasing the risk of infection. Additionally, antimicrobial-coated sutures, designed to prevent bacterial colonization at the wound site, are witnessing increased demand in response to rising concerns about surgical site infections (SSIs). The general occurrence of surgical site infections (SSI) following operations in Japan stands at 4.2%. In contrast, the incidence rate for gastrointestinal surgeries that involve the intestinal tract, known for its high concentration of commensal bacteria, is recorded at 7.2%. With healthcare providers emphasizing patient safety and postoperative outcomes, manufacturers are focusing on developing sutures with enhanced antimicrobial properties and biocompatibility. This trend is driving innovation in suture materials and coatings, further strengthening the Japan surgical sutures market share.

Advancements in Smart Sutures and Nanotechnology Integration

The integration of smart sutures and nanotechnology into surgical sutures is revolutionizing the market in Japan. Smart sutures, embedded with sensors, offer real-time monitoring of wound healing by detecting infection, pH changes, and tissue stress. These sutures provide critical insights that help in early diagnosis and timely medical intervention, improving patient recovery rates. Additionally, nanotechnology-enhanced sutures with drug-eluting properties are gaining popularity for their ability to deliver localized treatment, reduce inflammation, and enhance tissue regeneration. As Japan continues to lead in medical technology advancements, investments in research and development for next-generation sutures are rising, fostering innovation and improving surgical outcomes across various medical specialties. On 6^th August 2024, Shinobi Therapeutics obtained a grant of USD 59 million from Japan's Agency for Medical Research and Development (AMED) to further develop its iPS-T cell therapy targeting GPC3+ solid tumors. This funding increases the company's total financial backing to USD119 million, with the addition of new investors Yosemite and Mitsubishi UFJ Capital.

Growing Demand for Robotic-Assisted and Minimally Invasive Surgeries

The increasing adoption of robotic-assisted and minimally invasive surgical techniques is one of the significant Japan surgical sutures market trends. On 9^th May 2024, Sony created a microsurgery assistance robot featuring automatic instrument exchange and precise control, scheduled to be unveiled at ICRA2024 in Yokohama. This innovation aims to tackle the shortage of surgeons in Japan by mimicking hand movements for intricate procedures involving veins and nerves. In a trial conducted in February 2024 at Aichi Medical University, the robot achieved a significant milestone by successfully executing the world's first microvascular anastomosis utilizing automated instrument exchange. Surgeons are increasingly utilizing robotic systems for precision-driven procedures, necessitating the use of specialized sutures with superior tensile strength and flexibility. Minimally invasive surgeries, which require smaller incisions, have heightened the demand for micro and barbed sutures that enable secure wound closure with minimal tissue trauma. Furthermore, as hospitals and surgical centers prioritize efficiency and reduced recovery times, manufacturers are developing sutures tailored for laparoscopic and robotic surgeries. This trend is expected to continue as Japan’s healthcare sector embraces advanced surgical techniques, creating a positive Japan surgical sutures market outlook.

Japan Surgical Sutures Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the Japan surgical sutures market, along with forecasts at the country and regional levels from 2025-2033. The market has been categorized based on type, filament, application, and end use.

Analysis by Type:

• Absorbable
• Nonabsorbable

Absorbable sutures are essential in the Japanese surgical sutures market, especially since they ensure fast healing of wounds and a reduced number of suture removals. They are made from synthetic polymers or natural materials such as catgut and dissolve inside the body after some time. Increasing usage in internal tissue repair, particularly in surgeries including gastrointestinal, gynecological, and orthopedic surgeries, has enhanced the demand in the market. Additionally, developments in suture coatings as well as antimicrobial properties make them a more effective option for the surgeons who focus on the reduction of infection risks and better recovery of patients.

Nonabsorbable sutures provide long-lasting tissue support. Therefore, the sutures come in handy with procedures that have a need to close wounds over a long duration, such as cardiovascular and orthopedic surgery. Unlike their absorbable varieties, they consist of materials that include nylon, polypropylene, and silk, which will not degrade once placed inside the body. Chronic disease-related surgeries have risen in Japan. Cardiovascular and neurosurgical applications are major growth areas. More importantly, novel technologies developed within the suture material enhance the performance, safety of wound closure, and patient outcomes from surgical procedures by decreasing complications, such as dehiscence in patients whose wound healing takes an extended time to occur.

Analysis by Filament:

• Monovalent
• Multivalent

Monofilament sutures consist of a single, smooth strand. Therefore, there is minimal bacterial contamination risk, and tissue trauma is minimized. The structure provides easy passage through tissues; they are especially handy for delicate procedures such as cardiovascular and plastic surgeries. The demand for monofilament sutures has increased as the demand for minimally invasive surgery has increased in Japan. Advance developments in suture materials, such as developments in absorbable and nonabsorbable substances with increased tensile strengths, add to this increase in popularity among surgeons looking for reliable, friction-reducing sutures that enhance wound healing with minimal tissue irritation.

Multifilament sutures comprise twisted or braided numerous strands put together, thereby yielding excellent flexibility, secure knots, and tensile strength. Such multifilament sutures are essential in relatively complex surgical procedures that require solid support to wounds, such as orthopedic and gastrointestinal surgeries. In Japan, the continually increasing rates of surgical procedures have led to an increased demand for multifilament sutures, especially in high-tension areas. However, since their braided structure can harbor bacteria, antimicrobial-coated variants are increasingly developed to minimize infection risks, ensuring their continued use in critical surgical applications requiring enhanced durability and stability.

Analysis by Application:

• Ophthalmic Surgery
• Cardiovascular Surgery
• Orthopedic Surgery
• Neurological Surgery
• Others

Fine-gauge sutures in ophthalmic surgeries are used to minimize tissue damage and ensure speedy and effective healing. Improvement in the prevalence of cataracts, glaucoma, and retinal disorders in Japan will require more fine-gauge sutures particularly for delicate procedures in the eye. Monofilament and absorbable sutures are widely used to minimize scarring and promote recovery. The advancement in suture materials, including ultra-thin and biodegradable ones, improves surgical outcomes by reducing inflammation and promoting smooth tissue integration.

Cardiovascular surgeries require sutures that are very strong, biocompatible, and resistant to constant blood flow and tissue movement. In Japan, the incidence of heart diseases has risen, which has subsequently raised the use of durable and nonabsorbable sutures in valve replacement surgeries, and bypass surgeries. Monofilament sutures are preferred for reducing infection risks, while synthetic absorbable options provide temporary support. Innovations in coated sutures with enhanced tensile strength contribute to improved patient outcomes and long-term surgical success.

Orthopedic procedures require the use of sutures with good tensile strength to support the healing of the musculoskeletal system. Due to an aged population and sporting injuries, demands for strong sutures used to repair ligaments, reconstruct the joint, or fix bones, have increased over the years. Both absorbable and non-absorbable sutures are used based on the procedure. Advances in suture coatings and braided designs allow for increased security of knots for stable wound closure with minimal complications during healing.

Neurosurgical sutures must be highly precise and stable while minimizing tissue reaction. Brain and spinal surgery have been significantly on the rise in Japan, thus increasing the demand for ultra-fine biocompatible sutures. Monofilament sutures are commonly used for dural closure. These sutures maintain tissue integrity for a longer period of time as they are nonabsorbable. Microsurgical sutures with advancements such as antimicrobial coatings and improved elasticity are making it possible to be more precise during surgery and leading to better patient recovery, which makes them inevitable for delicate neurological procedures requiring cautious wound closure.

Analysis by End Use:

• Hospitals
• Ambulatory Surgical Centers and Clinics

Japan has a large network of hospitals managing a wide variety of complicated and critical cases, which form the main demand source for surgical sutures. Given the population is aging, along with increasing incidence of chronic diseases, advanced sutures for cardiovascular, orthopedic, and neurological surgery procedures are witnessing growth in demand. Hospitals also have a range of sutures they prefer-both absorbable and non-absorbable types. Technological advancements, such as tensile strength and antimicrobial coatings, are driving individuals to adopt sutures. Moreover, government healthcare initiatives as well as the improvement in surgical techniques increase demand for a high-quality suture in hospitals.

Ambulatory surgical centers (ASCs) and clinics are increasingly favored in Japan for their economical and efficient surgical options. These establishments are undertaking a rising volume of minimally invasive procedures, which in turn heightens the demand for precision sutures that facilitate expedited healing. ASCs generally utilize absorbable sutures for outpatient surgeries, thereby minimizing the necessity for subsequent removal. The growing inclination towards day-care surgeries, along with advancements in suture technology, is propelling demand in this sector. Furthermore, the transition towards outpatient care has bolstered the use of sutures engineered for faster recovery and diminished post-surgical complications.

Regional Analysis:

• Kanto Region
• Kansai/Kinki Region
• Central/ Chubu Region
• Kyushu-Okinawa Region
• Tohoku Region
• Chugoku Region
• Hokkaido Region
• Shikoku Region

The Kanto region, home to Tokyo and major medical institutions, dominates Japan’s surgical sutures market. Advanced healthcare infrastructure and high surgical volumes drive demand for specialized sutures. The presence of leading hospitals and research centers fosters innovation in suture materials. Additionally, increasing cardiovascular and orthopedic surgeries contribute to market growth in this highly developed region.

The Kansai region is one of the regions with solid healthcare infrastructures that facilitate surgical innovation; it primarily includes Osaka and Kyoto. A high volume of cardiovascular, neurological, and ophthalmic surgeries increases the demand for quality sutures. Top-notch hospitals and medical universities only add to the velocity. Government health initiatives and the aging population also contribute to an increased market for high-end surgical sutures.

The Chubu region benefits from well-established healthcare facilities in Nagoya and surrounding areas. With a rising elderly population, the Japan surgical sutures market demand is increasing, particularly in orthopedic and cardiovascular surgeries. The region’s growing medical device industry also supports advancements in suture technology. Expanding healthcare investments and improved surgical techniques further contribute to market growth in this area.

The Kyushu-Okinawa region is growing in the surgical sutures market as a result of aging of the population and an increase in chronic diseases. An increase in healthcare services and new hospitals requires high-quality sutures. Minimally invasive procedures are given much importance, and absorbable sutures are encouraged for better recovery of the patient and less post-operative complications.

The healthcare sector in Tohoku is witnessing steady growth, driven by improvements in medical infrastructure that have taken place following past disasters. The increasing need for surgical procedures, particularly in orthopedic and reconstructive surgery, is contributing to the growth of the suture market. Furthermore, government efforts to enhance healthcare accessibility in rural areas are also stimulating this rising demand.

The Chugoku region has a mix of urban and rural healthcare facilities, influencing the demand for surgical sutures. Hiroshima, the region’s medical hub, sees a rise in specialized surgeries, enhancing suture use. Government healthcare reforms and investments in hospital infrastructure improve access to surgical care. Additionally, increasing cases of chronic illnesses contribute to market expansion in this region.

Hokkaido’s cold climate and aging population drive demand for surgical procedures, particularly orthopedic and cardiovascular surgeries. Advanced hospitals in Sapporo lead innovations in surgical techniques, increasing the need for high-quality sutures. Rural healthcare improvements also play a role in market expansion, ensuring better access to surgical treatments and increasing the adoption of modern suture technologies in the region.

The Shikoku region, with its smaller but growing healthcare sector, is seeing steady demand for surgical sutures. Investments in hospital modernization and the increasing elderly population contribute to the market’s expansion. The rise in outpatient procedures in local clinics is also fueling the use of absorbable sutures. Government initiatives to enhance medical services further support market growth in the region.

Competitive Landscape:

The industry is highly characterized by intense research and development activities, strategic partnerships, and innovations in products. Leading Japanese manufacturers are focusing on developing advanced sutures with advanced tensile strength, biocompatibility, and antimicrobial properties, which should respond to the current demand for even more efficient and safe wound closure. Companies currently invest in the development of biodegradable and drug-eluting sutures to further reduce post-operative complications and guarantee better healing outcomes. Key participants are also looking to expand the distribution channels along with partnerships with hospitals and other surgical facilities, thereby enhancing the market presence. Innovations in technology, including smart sutures and materials compatible with robotic systems, are influencing competitive dynamics.

The report provides a comprehensive analysis of the competitive landscape in the Japan surgical sutures market with detailed profiles of all major companies.

Latest News and Developments:

• January 07, 2025: Kaken Pharmaceutical of Japan entered into a licensing agreement valued at USD 1.2 Billion with Johnson & Johnson for the worldwide development, production, and marketing of its STAT6 inhibitor program, which encompasses KP-723. Kaken is responsible for concluding Phase I trials before Johnson & Johnson assumes control of global clinical development, while Kaken will maintain commercialization rights within Japan. The agreement features an initial payment of USD 30 Million, milestone-related payments that could reach up to USD 1.2175 Billion, along with royalties on international sales.
• October 16, 2023: Japan's Gunze Limited announced allocating 3.5 billion JPY for the construction of a third medical facility and the expansion of its research and development laboratory in Ayabe, Kyoto, with a target completion date of February 2025. This initiative aims to strengthen its medical sector. The new plant will facilitate increased production of TENALEAF™, an absorbable surgical adhesive barrier, while also enhancing research and development efforts for next-generation products.

Japan Surgical Sutures Market Report Scope:

Key Benefits for Stakeholders:

• IMARC’s report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the Japan surgical sutures market from 2019-2033.
• The research study provides the latest information on the market drivers, challenges, and opportunities in the Japan surgical sutures market.
• Porter's Five Forces analysis assists stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the Japan surgical sutures industry and its attractiveness.
• Competitive landscape allows stakeholders to understand their competitive environment and provides an insight into the current positions of key players in the market.